Back to results
US 6,515,117 B2Granted
C-aryl glucoside SGLT2 inhibitors and method
AssigneeBristol-Myers Squibb Company
InventorsBruce Ellsworth, William N. Washburn, Philip M. Sher, Gang Wu, Wei Meng
Life of this patent
Estimating the term…
Abstract
An SGLT2 inhibiting compound is provided having the formula A method is also provided for treating diabetes and related diseases employing an SGLT2 inhibiting amount of the above compound alone or in combination with another antidiabetic agent or other therapeutic agent.
Claims17
A compound having the structure
- or a pharmaceutically acceptable salt, a stereoisomer thereof, or a prodrug ester thereof.
A compound having the structure
- or a pharmaceutically acceptable salt thereof, all stereolsomers thereof, or a prodrug ester thereof.
Dependencies are inferred from the claim text.